SAMED Market Access Forum: CMS Reports as a Market Access Tool

Description

Clinical Trials are a rich source of information for engaging healthcare providers and funders. Nicholas Finn from WITS Health Consortiums will share the Wits Health Consortium and their Division Wits Clinical Research including, offering as an economic clinical trials destination with integrated academic support including ethics approvals in a diverse and inclusive population.

The Council for Medical Scheme’s reports can be a valuable tool for engaging medical providers and funders on medtech Market Access matters. In this forum, Elsabe Klinck will share how to lift important information from the reports and use it to substantiate discussions with providers and funders.

• Address designated service providers versus preferred suppliers
• Differentiate between open and closed schemes and administrators
• Understand managed care rules, protocols and formularies
• Review data limitations – PMBs vs Rare Diseases
• Unpack how to leverage co-pay data
• Learn how to expropriate data to substantiate market share
• Receive tips on engaging with schemes to ensure progress meeting to meeting